Abstract
INTRODUCTION
Altered neurometabolism, detectable via proton magnetic resonance spectroscopic imaging (1H-MRSI), is spatially heterogeneous and underpins cognitive impairments in Alzheimer’s disease (AD). However, the spatial relationships between neurometabolic topography and cognitive impairment in AD remain unexplored due to technical limitations.
METHODS
We used a novel whole-brain high-resolution 1H-MRSI technique, with simultaneously acquired 18F-florbetapir positron emission tomography (PET) imaging, to investigate the relationship between neurometabolic topography and cognitive functions in 117 participants, including 22 prodromal AD, 51 AD dementia, and 44 controls.
RESULTS
Prodromal AD and AD dementia patients exhibited spatially distinct reductions in N-acetylaspartate, and increases in myo-inositol. Reduced N-acetylaspartate and increased myo-inositol were associated with worse global cognitive performance, and N-acetylaspartate correlated with five specific cognitive scores. Neurometabolic topography provides biological insights into diverse cognitive dysfunctions.
DISCUSSION
Whole-brain high-resolution 1H-MRSI revealed spatially distinct neurometabolic topographies associated with cognitive decline in AD, suggesting potential for noninvasive brain metabolic imaging to track AD progression.
Highlights
Whole-brain high-resolution 1H-MRSI unveils neurometabolic topography in AD.
Spatially distinct reductions in NAA, and increases in mI, are demonstrated.
NAA and mI topography correlates with global cognitive performance.
NAA topography correlates with specific cognitive performance.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: Jialin Hu,
Miao Zhang,
Yaoyu Zhang,
Huixiang Zhuang,
Yibo Zhao,
Yudu Li,
Wen Jin,
Xiao‐Hang Qian,
Lijun Wang,
Guanyu Ye,
Huidong Tang,
Jun Liu,
Biao Li,
Parashkev Nachev,
Zhi‐Pei Liang,
Yao Li | July 29, 2024